Tout DSpace

Afficher la notice abrégée

Is MGMT the best marker to predict response of temozolomide in aggressive pituitary tumors? Alternative markers and prospective treatment modalities

dc.creatorKontogeorgos G., Thodou E.en
dc.date.accessioned2023-01-31T08:44:01Z
dc.date.available2023-01-31T08:44:01Z
dc.date.issued2019
dc.identifier10.1007/s42000-019-00145-1
dc.identifier.issn11093099
dc.identifier.urihttp://hdl.handle.net/11615/75078
dc.description.abstract[No abstract available]en
dc.language.isoenen
dc.sourceHormonesen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85074998525&doi=10.1007%2fs42000-019-00145-1&partnerID=40&md5=d8de2f818a05fc0955b1ecab8bf0b785
dc.subjectbevacizumaben
dc.subjectDNA mismatch repair protein MSH2en
dc.subjecteverolimusen
dc.subjectgefitiniben
dc.subjectipilimumaben
dc.subjectKi 67 antigenen
dc.subjectlapatiniben
dc.subjectmethylated DNA protein cysteine methyltransferaseen
dc.subjectMutL protein homolog 1en
dc.subjectnivolumaben
dc.subjectprotein MSH6en
dc.subjectprotein p53en
dc.subjecttemozolomideen
dc.subjectalkylating agenten
dc.subjectDNA ligaseen
dc.subjectDNA methyltransferaseen
dc.subjectMGMT protein, humanen
dc.subjecttemozolomideen
dc.subjecttumor markeren
dc.subjecttumor suppressor proteinen
dc.subjectcorrelation analysisen
dc.subjectEditorialen
dc.subjecthumanen
dc.subjecthypophysis tumoren
dc.subjectimmunohistochemistryen
dc.subjectimmunoreactivityen
dc.subjectprotein depletionen
dc.subjectprotein expressionen
dc.subjectprotein methylationen
dc.subjecttreatment responseen
dc.subjectgeneticsen
dc.subjecthypophysis tumoren
dc.subjectprognosisen
dc.subjectAntineoplastic Agents, Alkylatingen
dc.subjectBiomarkers, Tumoren
dc.subjectDNA Modification Methylasesen
dc.subjectDNA Repair Enzymesen
dc.subjectHumansen
dc.subjectPituitary Neoplasmsen
dc.subjectPrognosisen
dc.subjectTemozolomideen
dc.subjectTumor Suppressor Proteinsen
dc.subjectSpringeren
dc.titleIs MGMT the best marker to predict response of temozolomide in aggressive pituitary tumors? Alternative markers and prospective treatment modalitiesen
dc.typeotheren


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée